Novartis Takes Aim At Watson Over Lotrel
Swiss pharmaceutical company Novartis Corp. is suing generic drug maker Watson Pharmaceuticals on charges of infringement concerning Novartis' hypertension treatment Lotrel....To view the full article, register now.
Already a subscriber? Click here to view full article